The new hepatitis C virus bottleneck: Can delaying therapy be justified?

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|3|666-667

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.3, 2015-09, pp. : 666-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 397-408

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections

By  

HEPATOLOGY, Vol. 61, Iss. 2, 2015-02 ,pp. : 712-721

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relationship between vitamin D status and response to hepatitis C virus therapy

By  

HEPATOLOGY, Vol. 62, Iss. 5, 2015-11 ,pp. : 1642-1643

John Wiley & Sons Inc

Access to resources Recommend Favorite

Value anti–hepatitis C virus therapy by its clinical efficacy

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 334-336

John Wiley & Sons Inc

Access to resources Recommend Favorite

Accurate Prediction of Response to Interferon Therapy by Repeated Measurement of Hepatitis C Virus Core Protein in Patients with Chronic Hepatitis C

By  

Intervirology, Vol. 45, Iss. 2, 2002-07 ,pp. : 105-110

Karger

Access to resources Recommend Favorite